EGFR and bone metastasis: In 2014, Keam et al. developed a nomogram based on disease status (recurrent and metastatic), PS, line of TKI, response to EGFR-TKIs, and bone metastasis [39] based on an analysis of 306 patients undergoing TKI therapy.